Search research articles
Contact Us
Filters
Showing results (121-130 of 125) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 125 results.
Molecular Biology of the Cell
|
January 22, 2025
The kinesin Kar3 is required for endoplasmic reticulum-associated degradation
Emmanuel Akoto, Ellen M Doss, Kieran P Claypool, et al.
Nigerian Journal of Clinical Practice
|
May 6, 2025
Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis
N O Kalkan, G Ucar, S A Esen, et al.
Lancet (London, England)
|
February 14, 2021
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer, Saadettin Kilickap, Mahmut Gümüş, et al.
The Journal of Biological Chemistry
|
June 18, 2023
Lipid biosynthesis perturbation impairs endoplasmic reticulum-associated degradation
Samantha M Turk, Christopher J Indovina, Jacob M Miller, et al.
Allergy
|
February 6, 2026
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
T Zuberbier, Z Abdul Hameed Ansari, A H Abdul Latiff, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 125) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 125 results.
Molecular Biology of the Cell
|
January 22, 2025
The kinesin Kar3 is required for endoplasmic reticulum-associated degradation
Emmanuel Akoto, Ellen M Doss, Kieran P Claypool, et al.
Nigerian Journal of Clinical Practice
|
May 6, 2025
Assessing the Efficacy and Safety of Shorter versus Extended Adjuvant Treatment Duration for Stage III Low-Risk Colon Cancer: A Comparative Analysis
N O Kalkan, G Ucar, S A Esen, et al.
Lancet (London, England)
|
February 14, 2021
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer, Saadettin Kilickap, Mahmut Gümüş, et al.
The Journal of Biological Chemistry
|
June 18, 2023
Lipid biosynthesis perturbation impairs endoplasmic reticulum-associated degradation
Samantha M Turk, Christopher J Indovina, Jacob M Miller, et al.
Allergy
|
February 6, 2026
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
T Zuberbier, Z Abdul Hameed Ansari, A H Abdul Latiff, et al.
Page
of 13